The Gene to Antibody Company ™

Antibody discovery against any target

Genovac offers the world’s most advanced antibody discovery solutions. Our innovative immunization technologies combined with our advanced hybridoma and Berkeley Lights Beacon platform provides success against the most challenging targets. We partner with all leading transgenic animal companies and offer everything from cDNA synthesis to antibody sequencing.

Discovery Technologies

Opening new worlds for Biotech and Pharma

Our pioneering science, trusted proprietary technologies and commitment to continuous improvement has made us leaders in the discovery of antibodies against challenging targets such as ion channels and GPCRs. We’re proud to join our clients pursuit of the most innovative solutions to the challenge of developing therapeutic and diagnostic products.

The Genovac Way
>3k We have completed over 3,000 antibody discovery projects. We pride ourselves on delivering hits where our competitors fail.

WE DELIVER MORE HITS IN THE SHORTEST POSSIBLE TIME

Our technologies dramatically increase the speed, robustness and precision with which we discover and produce new antibodies. We’re committed to delivering high value antibodies against the most difficult targets to enable our clients programs and reduce development timelines.

Listen to our latest webinar:
Tackle difficult targets by accessing broad B cell diversity. Listen here.

 

Latest Webinar
20+ Genovac has over 20 years experience in antibody discovery. Working with us brings a wealth of know-how into your team.

By continuing to use this website, you agree to our Cookie Policy.